Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Sanofi and Translate Bio begin phase I/II study of MRT-5500 mRNA COVID-19 vaccine candidate

March 12, 2021

Direct bladder vaccination halts recurrent UTIs

March 12, 2021

Novel antibody cocktail prevents SARS-CoV-2 viral escape mutations

March 12, 2021

Sichuan Haisco Pharmaceutical synthesizes influenza virus hemagglutinin inhibitors

March 12, 2021

Moderna begins dosing with modified COVID-19 vaccines in amended phase II study

March 12, 2021

First clinical results reported for SeVRSV vaccine in healthy adults

March 12, 2021

Venatorx selects VNRX-9945 as clinical candidate against HBV

March 12, 2021

CEPI and VBI Vaccines partner to develop eVLP vaccine candidates against COVID-19 variants

March 12, 2021

Kintor reports reduced mortality with proxalutamide in hospitalized COVID-19 patients

March 11, 2021

New phase I trial evaluates ST-266 in patients with COVID-19

March 11, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...